Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:28 PM ET 8-K
Loan & Debt Meta Platforms, Inc. META

Meta Platforms Debt Financing Update with Citigroup Global Markets Limited

Meta Platforms, Inc. completed a multi-tranche offering of Senior Notes denominated in Euros across six different maturities ranging from 2031 to 2065. The offering includes €1.75B of 4.300% notes due 2031, €1.25B of 4.650% notes due 2033, €1.00B of 4.900% notes due 2035, €1.75B of 5.400% notes due 2038, €1.75B of 6.050% notes due 2044, and €1.50B of 6.400% notes due 2065. The notes were issued under a seventh supplemental indenture with U.S. Bank Trust Company as trustee.

Counterparty
Citigroup Global Markets Limited and Morgan Stanley & Co. International plc
Term
through 2065
4:28 PM ET 10-Q
Financial Results Robinhood Ventures Fund II RVII

Robinhood Ventures Fund II Q2 2026 Results: Net Loss of $1.88M

Robinhood Ventures Fund II reported a net investment loss of $1.87 million for the six months ended September 30, 2026, with total assets growing significantly to $217.1 million following its IPO in August 2026. The fund's net asset value per share decreased from $24.72 to $23.21 during the period, primarily driven by organizational expenses and offering costs.

Key figure
Net loss $1.88M
4:28 PM ET Form 4
Insider Selling Tim S.A. TIMB

Tim VP, Risk & Compliance Claudio Creo Sells $18.9K of Stock

Claudio Creo, VP, Risk & Compliance, sold 5,000 shares of Tim S.A. at $3.77 a share, worth $18.9K in total on Nov 10, 2026. Shares held after the trade: 21,798 (+29.8%).

Value
$18.9K
Shares
5,000
Price
$3.77
Role
VP, Risk & Compliance
Holding change
+29.8%
Trade date
Nov 10, 2026
4:28 PM ET Form 4
Insider Buying Orchestra BioMed Holdings, Inc. OBIO

Orchestra BioMed Holdings 10% Owner Rtw Investments LP Buys $6M of Stock

Rtw Investments LP, 10% Owner, bought 1,200,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 a share, worth $6M in total on Nov 9, 2026. Shares held after the trade: 10,756,063 (+12.6%).

Value
$6M
Shares
1,200,000
Price
$5.00
Role
10% Owner
Holding change
+12.6%
Trade date
Nov 9, 2026
4:27 PM ET 10-Q
Financial Results Ondas Inc. ONDS ▶ Call

Ondas Q3 2026 Results: Net Loss of $64.7M, Loss Widens

Ondas Inc. reported a significant revenue increase to $301.4 million for the nine months ended September 30, 2026, compared to $20.6 million in the prior year, primarily driven by acquisition activity. Despite a quarterly net loss of $64.7 million, the company achieved a net income of $206.9 million for the nine-month period, largely due to $583.4 million in other income.

Key figure
Net loss $64.7M
4:27 PM ET 8-K
Capital Raise Candel Therapeutics, Inc. CADL

Candel Therapeutics Capital Raise

Candel Therapeutics entered into a Second Amended and Restated Open Market Sale Agreement with Jefferies LLC to establish a new at-the-market (ATM) equity facility. The agreement allows the company to sell up to $50 million of common stock from time to time, in addition to the $50 million previously sold under a prior 2025 agreement.

Counterparty
Jefferies LLC
4:27 PM ET 10-Q
Financial Results Armata Pharmaceuticals, Inc. ARMP

Armata Pharmaceuticals Q3 2026 Results: Turns Profitable, Net Income $54.9M

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on bacteriophage-based therapies. As of November 6, 2026, the company had 37,192,632 shares of common stock outstanding and is classified as a non-accelerated filer and smaller reporting company.

Key figure
Net income $54.9M
4:27 PM ET 10-Q
Financial Results Xos, Inc. XOS

Xos Q3 2026 Results: Net Loss of $7.61M

For the nine months ended September 30, 2026, Xos, Inc. reported revenues of $21.5 million, a significant decrease from $40.8 million in the prior year period. The company incurred a net loss of $19.4 million for the first nine months of 2026, while its cash position decreased to $12.1 million as of September 30, 2026.

Key figure
Net loss $7.61M
4:27 PM ET 10-Q
Financial Results Newsmax Inc. NMAX ▶ Call

Newsmax Q3 2026 Results: Turns Profitable, Net Income $15.2M

Newsmax Inc. reported a significant financial turnaround for the nine months ended September 30, 2026, achieving a net income of $15.9 million compared to a net loss of $96.5 million in the prior year period. This improvement was driven by a 27.6% increase in total revenues to $174.8 million and a substantial reduction in general and administrative expenses, which had been inflated in 2025 by one-time corporate matters.

Key figure
Net income $15.2M
4:26 PM ET 10-Q
Financial Results iANTHUS Capital HOLDINGS, INC. ITHUF

iANTHUS Capital HOLDINGS Q3 2026 Results: Net Loss of $13.2M, Loss Widens

For the nine months ended September 30, 2026, iAnthus reported net revenues of $107.2 million and a net loss of $41.9 million, compared to a net loss of $26.1 million in the prior year period. The company's balance sheet shows a significant shift in debt classification, with $208.7 million in long-term debt moving to current liabilities, contributing to a total shareholders' deficit of $143.5 million.

Key figure
Net loss $13.2M
4:26 PM ET Form 4
Insider Selling Caci International Inc CACI

Caci International Insider Debora A. Plunkett Sells $152K of Stock

Debora A. Plunkett sold 235 shares of Caci International Inc at $646.31 a share, worth $152K in total on Nov 11, 2026. Shares held after the trade: 2,447 (-8.8%).

Value
$152K
Shares
235
Price
$646.31
Holding change
-8.8%
Trade date
Nov 11, 2026
4:26 PM ET 10-Q
Financial Results Nuveen Farmland REIT

Nuveen Farmland REIT Q3 2026 Results: Net Loss of $607K

Nuveen Farmland REIT commenced operations in late 2026, completing its initial closing on September 1, 2026, with $34.7 million in proceeds and acquiring an initial portfolio of two assets. For the nine months ended September 30, 2026, the company reported a net loss of $607,000, primarily driven by general and administrative expenses as it established its investment platform.

Key figure
Net loss $607K
4:26 PM ET 10-Q
Financial Results Ionic Digital Inc. IOND

Ionic Digital Q3 2026 Results: Turns Profitable, Net Income $17.4M

Ionic Digital Inc. reported a significant shift in its business model, with digital infrastructure leasing revenue of $131.7 million for the nine months ended September 30, 2026, surpassing its cryptocurrency mining revenue. Despite a net loss of $30.9 million for the nine-month period, the company achieved a net income of $17.4 million in the third quarter, bolstered by a $73.2 million gain on the fair value of cryptocurrency assets.

Key figure
Net income $17.4M
4:26 PM ET 10-Q
Financial Results Vivos Inc RDGL

Vivos Q3 2026 Results: Net Loss of $732K, Loss Widens

Vivos Inc. reported a net loss of $2,746,628 for the nine months ended September 30, 2026, compared to a loss of $1,987,503 in the prior year period, driven largely by a $847,628 non-operating loss on share issuances. While revenues increased significantly to $101,368 from $43,627, the company continues to operate with a substantial accumulated deficit of over $91 million.

Key figure
Net loss $732K
4:26 PM ET 8-K
Reverse Stock Split Kala BIO, Inc. KALA

Kala BIO Reverse Stock Split

KALA BIO filed a Certificate of Amendment to effect a 1-for-30 reverse stock split of its common stock, effective November 13, 2026. The split will reduce the number of outstanding shares from approximately 19.3 million to approximately 644,659 to meet market requirements. Shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market on November 16, 2026.

4:26 PM ET 8-K
Financial Results Nektar Therapeutics NKTR

Nektar Therapeutics Financial Results

Nektar Therapeutics reported third quarter 2026 financial results, highlighting a cash position of $952.9 million and the initiation of Phase 3 registrational trials for rezpegaldesleukin in atopic dermatitis. The company reported a net loss of $55.7 million on revenue of $9.4 million, with R&D expenses increasing to support its late-stage clinical programs.

Term
Q3 2026

“This was a pivotal quarter for Nektar as we moved rezpegaldesleukin quickly into Phase 3 development. We have now initiated all three global ZENITH AD registrational trials in atopic dermatitis and our global ZENITH AA registrational trial in alopecia areata is on track to begin in December, earlier than previously planned.”

Howard Robin, President and Chief Executive Officer of Nektar
4:25 PM ET 10-Q
Financial Results Innovate Corp. VATE

Innovate Q3 2026 Results: Turns Profitable, Net Income $26.5M

INNOVATE Corp. reported a significant turnaround for the third quarter of 2026, with net income attributable to common stockholders of $15.8 million compared to a net loss of $9.4 million in the prior year. Revenue grew to $495.5 million for the quarter, driven by operations and a $32.9 million gain on the sale of a controlling interest in a subsidiary.

Key figure
Net income $26.5M
4:25 PM ET 8-K
Nasdaq/NYSE Compliance Notice Beneficient BENF

Beneficient Nasdaq/NYSE Compliance Notice

Beneficient received a deficiency notice from Nasdaq on November 5, 2026, because its market value of listed securities (MVLS) fell below the $35 million minimum requirement for 30 consecutive business days. The company has until May 4, 2027, to regain compliance by maintaining an MVLS of at least $35 million for at least ten consecutive business days. The notice has no immediate effect on the listing of the company's Class A common stock (BENF) or warrants (BENFW).

Counterparty
Nasdaq
Term
180 days
4:25 PM ET Form 4
Insider Buying BRT Apartments Corp. BRT

BRT Apartments Chairman of the Board Matthew J. Gould Buys $39.4K of Stock

Matthew J. Gould, Chairman of the Board, bought 3,000 shares of BRT Apartments Corp. at $13.14 a share, worth $39.4K in total on Nov 9, 2026. Shares held after the trade: 3,000.

Value
$39.4K
Shares
3,000
Price
$13.14
Role
Chairman of the Board
Trade date
Nov 9, 2026
4:25 PM ET 8-K/A
Shareholder Meeting Tapestry, Inc. TPR

Tapestry Shareholder Meeting

Tapestry, Inc. held its 2026 Annual Meeting of Stockholders where eleven directors were elected to serve until the 2027 meeting. Stockholders also ratified Deloitte & Touche LLP as the independent auditor, approved executive compensation on an advisory basis, and approved a stockholder proposal regarding action by written consent.

4:25 PM ET Form 4
Insider Selling Motorola Solutions, Inc. MSI

Motorola Solutions Chairman and CEO Gregory Q. Brown Sells $13.2M of Stock

Gregory Q. Brown, Chairman and CEO, sold 25,000 shares of Motorola Solutions, Inc. at $521.30 to $529.73 a share (average $526.14) in 10 transactions, worth $13.2M in total on Nov 10, 2026. Shares held after the trade: 66,769 (-0.2%).

Value
$13.2M
Shares
25,000
Average price
$526.14
Role
Chairman and CEO
Holding change
-0.2%
Trade date
Nov 10, 2026
4:24 PM ET 8-K
Financial Results Armata Pharmaceuticals, Inc. ARMP

Armata Pharmaceuticals Financial Results

Armata Pharmaceuticals reported its third quarter 2026 financial results and provided an update on its AP-SA02 Phase 3 program. The company is finalizing study designs with the FDA and has completed engineering runs at its cGMP manufacturing facility to support the upcoming pivotal trial.

“We continue to advance toward our most important near-term objective: initiating the Phase 3 superiority study of AP-SA02. We have progressed from planning to establishing the operational infrastructure needed to execute a large, pivotal clinical study.”

Dr. Deborah Birx, Chief Executive Officer

“We believe the FDA’s recent Breakthrough Therapy designation further underscores AP-SA02’s clinical potential. We also appreciate the continued financial support of the U.S. Department of War (“DoW”), which comes at an important time as we prepare for this next critical stage of clinical development.”

Dr. Deborah Birx, Chief Executive Officer
4:24 PM ET 10-Q
Financial Results Innventure, Inc. INV

Innventure Q3 2026 Results: Net Loss of $202M, Loss Widens

Innventure, Inc. reported a significant net loss for the nine months ended September 30, 2026, primarily driven by a $323.5 million goodwill impairment charge. While revenue increased to $3.88 million from $1.23 million year-over-year, the company faces substantial liquidity risks and is exploring strategic alternatives for its subsidiaries AeroFlexx and Refinity.

Key figure
Net loss $202M
4:24 PM ET 8-K
Financial Results FGI Industries Ltd. FGI

FGI Industries Financial Results

FGI Industries reported third quarter 2026 revenue of $31.7 million, an 11.6% year-over-year decline driven by softness in housing and remodeling activity. Despite the revenue drop, gross margin expanded by 110 basis points to 27.6% due to cost discipline and product mix management, though the company recorded a net loss of $0.9 million.

“FGI reported total revenue of $31.7 million in the quarter, representing a year-over-year decline of 11.6%. The quarter reflected a challenging market environment, with continued softness in housing and remodeling activity, reduced customer purchasing and delayed projects weighing on demand across several product categories.”

Dave Bruce, CEO of FGI

“Revenue declined 11.6% year-over-year in the third quarter, reflecting softness in our core North American sanitaryware and shower system categories. Operating expenses remained disciplined, declining on a year-to-date basis, and we continued to advance our commercial pipeline and strengthen sales reporting and account-level performance tracking.”

Jae Chung, Chief Financial Officer of FGI
4:24 PM ET 8-K
Loan & Debt Emerson Electric Co EMR

Emerson Electric $830M Debt Financing with J.P. Morgan Securities plc

Emerson Electric Co. entered into a pricing agreement for a public offering of €750 million aggregate principal amount of 4.000% Notes due 2032. The company expects net proceeds of approximately $830.4 million, which will be used primarily to repay commercial paper borrowings and for general corporate purposes.

Value
$830M
Counterparty
J.P. Morgan Securities plc
Term
through 2032
4:24 PM ET 8-K
Financial Results Xos, Inc. XOS

Xos Financial Results

Xos, Inc. reported its third quarter 2026 financial results, achieving its third consecutive quarter of positive GAAP gross profit and a 17% sequential revenue increase to $5.5 million. Despite a year-over-year revenue decline, the company improved its nine-month GAAP gross margin to 26.9% and reduced operating expenses by 10% through disciplined cost management.

Term
Q3 2026
4:24 PM ET 10-Q
Financial Results Codexis, Inc. CDXS ▶ Call

Codexis Q3 2026 Results: Net Loss of $8.13M, Loss Narrows

Codexis reported a significant increase in total revenues to $19.26 million for Q3 2026, up from $8.60 million in the prior year, driven primarily by product revenue growth. The company successfully reduced its quarterly net loss to $8.13 million compared to $19.62 million in Q3 2025, while strengthening its cash position through a $24.9 million net equity offering.

Key figure
Net loss $8.13M
4:23 PM ET Form 4
Insider Selling Metlife Inc MET

Metlife President & CEO Michel Khalaf Sells $19.3M of Stock

Michel Khalaf, President & CEO, sold 187,425 shares of Metlife Inc at $102.97 a share, worth $19.3M in total on Nov 10, 2026. Shares held after the trade: 759,013 (-19.8%).

Value
$19.3M
Shares
187,425
Price
$102.97
Role
President & CEO
Holding change
-19.8%
Trade date
Nov 10, 2026
4:23 PM ET Form 4
Insider Selling RPM International Inc RPM

RPM International Director Frederick R. Nance Sells $197K of Stock

Frederick R. Nance, Director, sold 1,896 shares of RPM International Inc at $103.97 a share, worth $197K in total on Nov 9, 2026. Shares held after the trade: 7,651 (-19.9%).

Value
$197K
Shares
1,896
Price
$103.97
Role
Director
Holding change
-19.9%
Trade date
Nov 9, 2026
4:23 PM ET 8-K
Nasdaq/NYSE Compliance Notice Rain Enhancement Technologies Holdco, Inc. RAIN

Rain Enhancement Technologies Holdco Nasdaq/NYSE Compliance Notice

Rain Enhancement Technologies Holdco received a deficiency notice from Nasdaq on November 6, 2026, because its Class A common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until May 5, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for at least ten consecutive business days.

Counterparty
Nasdaq Listing Qualifications Department
Term
180 days

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.